Trending Now
Iterum Therapeutics plc (NASDAQ: ITRM) Reports Net Income of $3.7 Million...
Iterum Therapeutics plc (NASDAQ: ITRM) has announced its Q3 2021 financial results in which net income was $3.7 million relative to a net loss...
DIH Holding US, Inc. (DHAI): Pioneering Rehabilitation with Cutting-Edge Technology
Let’s talk about something truly inspiring: the future of rehabilitation. On December 23, 2024, DIH Holding US, Inc. (NASDAQ: DHAI) announced...
Predictive Oncology Inc. (Nasdaq: POAI): A Transformative Acquisition by Renovaro Inc.
The biotechnological domain is currently abuzz with developments surrounding the acquisition of Predictive Oncology Inc. (Nasdaq: POAI) by Renovaro Inc. (Nasdaq: RENB)....
Popular News
Moleculin Biotech Inc. (NASDAQ:MBRX) Receives Rare Paediatric Disease Designation For WP1066...
Moleculin Biotech Inc. (NASDAQ:MBRX) has announced that the FDA has approved its Rare Paediatric Disease designation request for the WP1066 drug candidate. The designation...
MAKE IT MODERN
LATEST REVIEWS
ARCA Biopharma (ABIO) Announces Special Dividend Amid Merger with Oruka Therapeutics
ARCA biopharma, Inc. (NASDAQ: ABIO), a trailblazer in the development of targeted therapies for cardiovascular diseases, saw its shares jump over 21%...
MAKE IT MODERN
PERFORMANCE TRAINING
Atossa Therapeutics Inc. (NASDAQ: ATOS) Receives Approval For Commencement Of Phase 2 Oral Endoxifen...
Atossa Therapeutics Inc. (NASDAQ: ATOS) has announced that the Swedish Ethics Review Authority has given it the approval to commence Phase 2 oral Endoxifen...
Tauriga Sciences Inc (OTCMKTS:TAUG) Blasts Onto the Radar
One stock that could pop onto a lot of radars this week is Tauriga Sciences Inc (OTCMKTS:TAUG). The company is a revenue generating, diversified...
Kintara Therapeutics (NASDAQ: KTRA) Posted Net Loss of $1.6 Per Share in Fiscal 2021
Kintara Therapeutics (NASDAQ: KTRA) has announced its financial results for the fiscal year ending June 30, 2021, and offered a corporate update.
Corporate update
Recently the...
Why the EV Pullback Could be a Once-in-a-Lifetime Opportunity for Investors (TSLA, DSGT, XPEV,...
If there’s one stat that really shows the growth potential in the electric vehicle space over coming years, it’s this: EVs accounted...
Cassava Sciences Inc (NASDAQ: SAVA) Announces Positive Data in Alzheimer’s Disease
Cassava Sciences Inc (NASDAQ: SAVA) aims to find and develop unique treatments for Chronic, neurodegenerative conditions. The company announced the positive Biomarker and Cognition...
MAKE IT MODERN
